XML 84 R25.htm IDEA: XBRL DOCUMENT v3.24.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Transations

The following table summarizes the stock option transactions for the 2006 and 2023 Plans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Options

 

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (years)

 

 

 

Aggregate Intrinsic Value (in thousands)

 

Outstanding at December 31, 2022

 

 

739,511

 

 

$

 

6.94

 

 

 

7.36

 

 

$

 

8,903

 

Assumed in the Merger

 

 

310,431

 

 

 

 

76.72

 

 

 

 

 

 

 

 

Granted

 

 

785,922

 

 

 

 

6.48

 

 

 

 

 

 

 

 

Cancelled

 

 

(96,594

)

 

 

 

70.51

 

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

1,739,270

 

 

$

 

15.71

 

 

 

6.99

 

 

$

 

76

 

Vested and exercisable at December 31, 2023

 

 

940,098

 

 

$

 

6.18

 

 

 

5.97

 

 

$

 

76

 

Schedule of Assumptions Using Black-Scholes to Estimate Fair Value of the Stock Option Grants

The following is the range of underlying assumptions in Black-Scholes to determine the fair value of the stock option grants for the years ended December 31, 2023 and 2022:

 

 

 

Year Ended December 31,

 

 

2023

 

 

2022

Risk free interest rate

 

3.50%-3.56%

 

 

2.80%-3.28%

Expected volatility

 

75%-76%

 

 

82%

Expected term (years)

 

 

6.25

 

 

5.00-6.25

Expected dividend yield

 

0%

 

 

0%

 

Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted

Stock-based compensation expense recognized for options and restricted stock units granted was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Research and development

 

$

2,449

 

 

$

499

 

General and administrative

 

 

9,590

 

 

 

902

 

Total

 

 

12,039

 

 

 

1,401

 

Statement of convertible preferred stock and stockholders' equity (deficit)

 

 

 

 

 

 

Settlement of 2021 and 2020 accrued bonus and employee costs

 

 

 

 

 

406

 

Total stock-based compensation expense

 

$

12,039

 

 

$

1,807

 

Schedule of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following at December 31, 2023:

 

 

 

December 31,

 

 

 

2023

 

Common stock warrants

 

 

276,437

 

Stock options issued and outstanding

 

 

1,739,270

 

Shares available for issuance under the 2023 Plan

 

 

394,309

 

Shares available under the 2023 ESPP

 

 

65,000

 

Total

 

 

2,475,016